The Medicare Part D open enrollment period: What you and your audience need to know
With annual expenses running to about $100 billion last year, Medicare Part D is the dominant insurer in the U.S. pharmaceutical market.
Expert Commentary
Drug prices: Why prescription medicines remain unaffordable for many Americans
This explainer, in addition to providing an initial overview, addresses five aspects of the debate about the high costs of prescription medicines.
Expert Commentary
Coronavirus vaccines: We address 3 big questions about safety, distribution and adoption
As journalists work to keep communities informed about COVID-19 vaccines, they need to consider questions about safety, distribution and adoption. We address three specific questions, focusing on policies and processes in the U.S.
Expert Commentary
Reporting on coronavirus vaccines: 5 tips to help journalists inject audiences with the facts
To help reporters make sense of what’s known and yet to be learned about COVID-19 vaccines, we asked for insights from the experts.
Expert Commentary
Covering Medicaid during the COVID-19 pandemic: 6 things journalists should know
For reporters who are covering health care at the local or national level, it’s important to have a handle on how Medicaid works. Here are six things you should know.
Expert Commentary
7 tips for journalists reporting on surprise medical bills
A longtime health care journalist offers tips for reporting on “surprise billing,” in which people face unexpected medical expenses despite having private insurance coverage.
Expert Commentary
Surprise billing: Why consumers with medical insurance still may face major health care expenses
People in the United States frequently receive unexpectedly high hospital bills even after paying for health insurance, which they counted on to help them to manage their medical costs, several studies show.
Expert Commentary